A line of evidence found that cytochrome P450 (CYP) genes and catechol-O-methyltransferase (COMT) gene variants could influence enzyme activity and increase the risk of estrogen-dependent diseases, such as adenomyosis [122]. Here, COMT is linked to adenomyosis.